These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33133429)

  • 1. Fusion protein engineered exosomes for targeted degradation of specific RNAs in lysosomes: a proof-of-concept study.
    Li Z; Zhou X; Gao X; Bai D; Dong Y; Sun W; Zhao L; Wei M; Yang X; Yang G; Yuan L
    J Extracell Vesicles; 2020 Sep; 9(1):1816710. PubMed ID: 33133429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9.
    Li Z; Zhou X; Wei M; Gao X; Zhao L; Shi R; Sun W; Duan Y; Yang G; Yuan L
    Nano Lett; 2019 Jan; 19(1):19-28. PubMed ID: 30517011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Evolution of Ligands by Exosome Enrichment: A Proof-of-Concept Study for Exosome-Based Targeting Peptide Screening.
    Liu X; Yang X; Sun W; Wu Q; Song Y; Yuan L; Yang G
    Adv Biosyst; 2019 Feb; 3(2):e1800275. PubMed ID: 32627374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of exosome-targeting peptides via engineered glycosylation.
    Hung ME; Leonard JN
    J Biol Chem; 2015 Mar; 290(13):8166-72. PubMed ID: 25657008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Protein Degradation Mediated by Genetically Engineered Lysosome-Targeting Exosomes.
    Wang T; Sun L; Ren T; Hou M; Long Y; Jiang JH; He J
    Nano Lett; 2023 Oct; 23(20):9571-9578. PubMed ID: 37823825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia.
    Yang J; Zhang X; Chen X; Wang L; Yang G
    Mol Ther Nucleic Acids; 2017 Jun; 7():278-287. PubMed ID: 28624203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
    Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
    J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang B; Zhang A; Wang H; Klein JD; Tan L; Wang ZM; Du J; Naqvi N; Liu BC; Wang XH
    Theranostics; 2019; 9(7):1864-1877. PubMed ID: 31037144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes.
    Kim H; Yun N; Mun D; Kang JY; Lee SH; Park H; Park H; Joung B
    Biochem Biophys Res Commun; 2018 May; 499(4):803-808. PubMed ID: 29621543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
    Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
    Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p.
    Zhao Z; Zhong L; Li P; He K; Qiu C; Zhao L; Gong J
    Exp Cell Res; 2020 Feb; 387(1):111738. PubMed ID: 31759057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "All-in-One" Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia.
    Mei R; Wan Z; Li Z; Wei M; Qin W; Yuan L; Liu L; Yang G
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):50626-50636. PubMed ID: 36342824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-Wide Transgene Expression in Mice by Systemic Injection of Genetically Engineered Exosomes: CAP-Exosomes.
    Sarkar SN; Corbin D; Simpkins JW
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extracellular Matrix Enriched With Exosomes for the Treatment on Pulmonary Fibrosis in Mice.
    Yu Y; Liu X; Zhao Z; Xu Z; Qiao Y; Zhou Y; Qiao H; Zhong J; Dai J; Suo G
    Front Pharmacol; 2021; 12():747223. PubMed ID: 34938180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Exosomes for Targeted Transfer of siRNA to HER2 Positive Breast Cancer Cells.
    Limoni SK; Moghadam MF; Moazzeni SM; Gomari H; Salimi F
    Appl Biochem Biotechnol; 2019 Jan; 187(1):352-364. PubMed ID: 29951961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.
    Di Bonito P; Chiozzini C; Arenaccio C; Anticoli S; Manfredi F; Olivetta E; Ferrantelli F; Falcone E; Ruggieri A; Federico M
    Int J Nanomedicine; 2017; 12():4579-4591. PubMed ID: 28694699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells.
    Bai J; Duan J; Liu R; Du Y; Luo Q; Cui Y; Su Z; Xu J; Xie Y; Lu W
    Asian J Pharm Sci; 2020 Jul; 15(4):461-471. PubMed ID: 32952669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib.
    Dong Y; Lin Y; Gao X; Zhao Y; Wan Z; Wang H; Wei M; Chen X; Qin W; Yang G; Liu L
    Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9569-9582. PubMed ID: 31701195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELEX-Based Screening of Exosome-Tropic RNA.
    Yamashita T; Shinotsuka H; Takahashi Y; Kato K; Nishikawa M; Takakura Y
    Biol Pharm Bull; 2017; 40(12):2140-2145. PubMed ID: 29199238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.